Advertisement

Irish Journal of Medical Science (1971 -)

, Volume 185, Issue 4, pp 941–943 | Cite as

Novel antibody associations in immune-mediated necrotising myopathy without inflammation

  • D. Curtin
  • D. Costigan
  • C. McCarthy
  • M. Jansen
  • M. Farrell
  • V. Reid
  • K. O’Rourke
Case Based Review

Abstract

Introduction

The patient presenting with proximal muscle weakness, elevated serum creatinine kinase and myopathic electromyography and biopsy findings has a wide differential diagnosis that includes toxic, autoimmune, paraneoplastic and congenital myopathies. Autoimmune myopathies are important to identify because they may respond to immunosuppressive therapies.

Methods

We describe two cases of immune-mediated necrotizing myopathy each associated with a novel antibody.

Results

Case 1 describes a progressive myopathy in a statin user. Antibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase were identified and the patient responded to steroid therapy. Case 2 describes an aggressive myopathy associated with antibodies to signal recognition particle. There was no response to steroids. Clinical improvement followed treatment with rituximab and cyclophosphamide.

Conclusion

The identification of myositis-specific antibodies is important because they are associated with distinct clinical phenotypes and may guide the physician in terms of treatment strategies.

Keywords

Immune mediated Necrotizing myopathy 3-Hydroxy-3-methyl-glutaryl-CoA reductase inhibitor Signal recognition particle Antibody 

Notes

Conflict of interest

None.

References

  1. 1.
    Sordet C, Goetz J, Sibilia J (2006) Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint bone Spine 73:646–654CrossRefPubMedGoogle Scholar
  2. 2.
    Kao A, Lacomis D, Lucas M, Fertig N, Oddis C (2004) Anti-signal recognition particle autoantibody in patients with and without idiopathic inflammatory myopathy. Arthritis Rheum 50:209–215CrossRefPubMedGoogle Scholar
  3. 3.
    Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L (2010) Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res 62:1328–1334CrossRefGoogle Scholar
  4. 4.
    Needham M, Fabian V, Knezevic W, Panegyres P, Zilko P, Mastaglia F (2007) Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord 17:194–200CrossRefPubMedGoogle Scholar
  5. 5.
    Mammen A, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering K, Casciola-Rosen L (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63:713–721CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Mammen AL, Pak K, Williams E, Brisson D, Coresh J, Selvin E, Gaudet D (2012) Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res (Hoboken) 64:269–272CrossRefGoogle Scholar
  7. 7.
    Morikawa S, Murakami T, Yamazaki H, Izumi A, Saito Y, Hamakubo T, Kodama T (2005) Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins. J Atheroscler Thromb 12:121–131CrossRefPubMedGoogle Scholar
  8. 8.
    Lee P, Greenfield J, Campbell L (2009) Vitamin D insufficiency—a novel mechanism of statin-induced myalgia? Clin Endocrinol (Oxf.) 71:154–155CrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2014

Authors and Affiliations

  • D. Curtin
    • 1
  • D. Costigan
    • 2
  • C. McCarthy
    • 3
  • M. Jansen
    • 4
  • M. Farrell
    • 4
  • V. Reid
    • 5
  • K. O’Rourke
    • 1
  1. 1.Dublin Neurological Institute at the Mater Misericordiae University HospitalDublin 7Ireland
  2. 2.Department of NeurologyMater Private HospitalDublinIreland
  3. 3.Department of RheumatologyMater Private HospitalDublinIreland
  4. 4.Department of NeuropathologyBeaumont HospitalDublinIreland
  5. 5.Department of Clinical NeurophysiologyMater Misericordiae University HospitalDublinIreland

Personalised recommendations